PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18059331-2	2008	Deletion of the p19/Arf or p53 tumor suppressor genes accelerates malignant progression and metastatic spread of 7,12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoyl-phorbol-13-acetate (TPA)-induced squamous cell carcinomas, providing a model system to address mechanisms of metastasis.	7,12-dimethylbenz	113-130	transformation related protein 53, pseudogene	Mus musculus	27-30	
15542785-0	2004	Modulation of p53 in 7,12-dimethylbenz[a]anthracene-induced skin tumors by diallyl sulfide in Swiss albino mice.	7,12-dimethylbenz	21-38	transformation related protein 53, pseudogene	Mus musculus	14-17	
8142019-0	1994	Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice.	7,12-dimethylbenz	28-45	transformation related protein 53, pseudogene	Mus musculus	11-14	
18234966-2	2008	Here, we show that p53(Ala135Val/wt) mice developed ovarian tumors significantly more rapidly than their wild-type littermates after 7,12-dimethylbenz(a)anthracene (DMBA) treatment.	7,12-dimethylbenz	133-150	transformation related protein 53, pseudogene	Mus musculus	19-22	
9849426-1	1998	The immunoreactivity of p53 protein was studied in relation to tumour development, histopathological characteristics, cell proliferation, and basement membrane organisation following the induction of skin carcinogenesis in tumour-sensitive and -resistant mouse strains by ultraviolet (UV) irradiation or 7,12-dimethylbenz(a)anthracene (DMBA).	7,12-dimethylbenz	304-321	transformation related protein 53, pseudogene	Mus musculus	24-27